Form HLTH5465 Special Authority Request - Donepezil, Galantamine, and Rivastigmine is used in British Columbia, Canada for requesting special authority coverage for these medications. It is meant to help individuals who require these specific medications for their medical condition to access them through the provincial drug plan.
The Form HLTH5465 Special Authority Request for Donepezil, Galantamine, and Rivastigmine in British Columbia, Canada is typically filed by healthcare professionals or physicians on behalf of their patients.
Q: What is HLTH5465 Special Authority Request?
A: HLTH5465 Special Authority Request is a form used in British Columbia, Canada to request coverage for the medications Donepezil, Galantamine, and Rivastigmine.
Q: What are Donepezil, Galantamine, and Rivastigmine?
A: Donepezil, Galantamine, and Rivastigmine are medications used to treat symptoms of Alzheimer's disease.
Q: Who can use the HLTH5465 Special Authority Request form?
A: The HLTH5465 Special Authority Request form can be used by residents of British Columbia, Canada who need coverage for Donepezil, Galantamine, or Rivastigmine.
Q: How does the Special Authority Request process work?
A: The Special Authority Request process involves completing the HLTH5465 form and submitting it to the appropriate authority for review. The authority will assess the request and determine if coverage for the medication is approved or not.
Q: What is the purpose of the Special Authority Request?
A: The purpose of the Special Authority Request is to ensure that individuals who meet specific criteria can access the medications Donepezil, Galantamine, and Rivastigmine, even if they are not normally covered under the provincial drug plan.
Q: Is there a fee for submitting the Special Authority Request?
A: No, there is no fee for submitting the Special Authority Request form.